Details for 2017790401

Up to date per 02.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN MIT SCHÄDLICHER IL-13 AKTIVITÄT UNTER VERWENDUNG VON ANTI-IL-13-ANTIKÖRPERN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017790401

EP Publication Number

3448391

E-Number

1690070

Language

PCT Number

US17029768

Publication Date

06.03.2019 A

29.05.2024 B1

Registration Date

29.05.2024

AT Publication Date

15.06.2024

Application Date

27.04.2017

Registration Number

Priorities

27.04.2016

201662328539 P

IPC

A61K 31/56 20060101AFI20191113BHEP

Maximum Duration of Protection

27.04.2037

Owner

AbbVie Manufacturing Management Unlimited Company70 Sir John Rogerson's Quay Dublin, 2IE

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

TIMONY, Gregg7333 Calle Pera Carlsbad, CA 92009US

GUJRATHI, SheilaP.O. Box 1395 Rancho Santa Fe, CA 92067US

PEACH, Robert3415 6th Avenue San Diego, CA 92103US

OLSON, Allan3033 Science Park Rd. Ste. 300 San Diego, CA 92121US

Information about Fees